Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q4 2024 (December 31)7holders −1
0new positions
1sold out
$22.10avg. 13F price*
At the end of Q4 2024, 7 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Sterling Capital Management LLC ($1.5M), Confluence Investment Management LLC ($847K) and Rhumbline Advisers ($622K).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $236K |
All 13F filers, Q3 2024 → Q4 2024: 1,466 shares bought and 16,827 shares sold, net −15,361 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Sterling Capital Management LLC | 0.02% | Reduce -7.1% | 66,693 | $1.5M |
| Confluence Investment Management LLC | 0.01% | Add +0.3% | 38,574 | $847K |
| Rhumbline Advisers | 0.00% | Reduce -4.7% | 28,321 | $622K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -3.8% | 13,993 | $307K |
| GAMMA Investing LLC | 0.02% | Add +10.9% | 8,223 | $181K |
| Brooklyn Investment Group | 0.01% | Add +51.8% | 1,582 | $35K |
| Richardson Financial Services Inc. | 0.00% | Reduce -50.0% | 14 | $308 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.